Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: Five cases

Osteoporosis International

Volumn 21, Issue 3, 2010, Pages 527-533

  Park, W ^a   Kim, N K ^a   Kim, M Y ^b   Rhee, Y M ^c   Kim, H J ^a  

^a Yonsei University College of Dentistry   (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Asian; Jaw; Oral administration of bisphosphonate; Osteonecrosis; Osteoporosis

Indexed keywords

ALENDRONIC ACID; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; CHLORHEXIDINE; CORTICOSTEROID; PREDNISONE;

AGED; ARTICLE; ASIAN; BONE BIOPSY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; COXITIS; CURETTAGE; DECORTICATION; DRUG WITHDRAWAL; FEMALE; GINGIVA BLEEDING; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOTHALAMUS TUMOR; JAW OSTEONECROSIS; OSTEOMYELITIS; OSTEOPOROSIS; PANORAMIC RADIOGRAPHY; PATIENT REFERRAL; PERIODONTITIS; PRIORITY JOURNAL; RACE; RHEUMATOID ARTHRITIS; RISK FACTOR; SENESCENCE; SKULL RADIOGRAPHY; TOOTH EXTRACTION; TOOTH IMPLANTATION; TOOTH PAIN; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; JAW DISEASES; OSTEONECROSIS; RADIOGRAPHY, PANORAMIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 76549104416     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-0973-3     Document Type: Article

References (42)

1. JJ Body 2006 Breast cancer: bisphosphonate therapy for metastatic bone disease Clin Cancer Res 12 6258s 6263s 10.1158/1078-0432.CCR-06-0840 1:CAS:528:DC%2BD28XhtFWhsbfL 17062710 (Pubitemid 44703799)
2. A Lipton 2007 Efficacy and safety of intravenous bisphosphonates in patients with bone metastases caused by metastatic breast cancer Clin Breast Cancer 7 Suppl 1 S14 S20 10.3816/CBC.2007.s.002 1:CAS:528:DC%2BD2sXhtFaltr3N 17683649
3. S Wu WL Dahut JL Gulley 2007 The use of bisphosphonates in cancer patients Acta Oncol 46 581 591 10.1080/02841860701233435 1:CAS:528: DC%2BD2sXmsVOisLk%3D 17562434 (Pubitemid 46911914)
4. V Elliot-Gibson ER Bogoch SA Jamal DE Beaton 2004 Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review Osteoporos Int 15 767 778 10.1007/s00198-004-1675-5 1:STN:280:DC%2BD2cvlvFGntQ%3D%3D 15258724 (Pubitemid 39361946)
5. Wells G, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2008) Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev CD004523
6. RE Marx 2008 Bisphosphonate-induced osteonecrosis of the jaws: a challenge, a responsibility, and an opportunity Int J Periodontics Restor Dent 28 5 6
7. F Bertoldo D Santini V Lo Cascio 2007 Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle Nat Clin Pract Oncol 4 711 721 10.1038/ncponc1000 1:CAS:528:DC%2BD2sXhtlCru7jK 18037875 (Pubitemid 350187006)
8. SL Ruggiero SJ Drew 2007 Osteonecrosis of the jaws and bisphosphonate therapy J Dent Res 86 1013 1021 10.1177/154405910708601101 1:CAS:528: DC%2BD2sXhtleku7rL 17959890
9. American Dental Association Council on Scientific Affairs 2006 Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations J Am Dent Assoc 137 1144 1150
10. SL Ruggiero J Fantasia E Carlson 2006 Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 433 441 10.1016/j.tripleo.2006.06.004 16997108 (Pubitemid 44403162)
11. AAOMS 2007 American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 65 369 376 10.1016/j.joms.2006.11.003 (Pubitemid 46329248)
12. Y Sawatari RE Marx 2007 Bisphosphonates and bisphosphonate induced osteonecrosis Oral Maxillofac Surg Clin North Am 19 487 498 10.1016/j.coms.2007. 07.003 18088900 v-vi
13. M Pazianas P Miller WA Blumentals M Bernal P Kothawala 2007 A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics Clin Ther 29 1548 1558 10.1016/j.clinthera.2007.08.008 1:CAS:528:DC%2BD2sXhtFyjt7jM 17919538 (Pubitemid 47500128)
14. RE Marx Y Sawatari M Fortin V Broumand 2005 Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment J Oral Maxillofac Surg 63 1567 1575 10.1016/j.joms.2005.07.010 16243172 (Pubitemid 41525412)
15. G Campisi O Di Fede A Musciotto A Lo Casto L Lo Muzio F Fulfaro G Badalamenti A Russo N Gebbia 2007 Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis Ann Oncol 18 vi168 vi172 10.1093/annonc/mdm250 17591816
16. R Rizzoli N Burlet D Cahall PD Delmas EF Eriksen D Felsenberg J Grbic M Jontell R Landesberg A Laslop M Wollenhaupt S Papapoulos O Sezer M Sprafka JY Reginster 2008 Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis Bone 42 841 847 10.1016/j.bone.2008.01.003 1:CAS:528: DC%2BD1cXkvVOqsbs%3D 18314405
17. A Bedogni S Blandamura Z Lokmic C Palumbo M Ragazzo F Ferrari A Tregnaghi F Pietrogrande O Procopio G Saia M Ferretti G Bedogni L Chiarini G Ferronato V Ninfo L Lo Russo L Lo Muzio PF Nocini 2008 Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105 358 364 10.1016/j.tripleo.2007. 08.040 18280968
18. SD Bianchi M Scoletta FB Cassione G Migliaretti M Mozzati 2007 Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 249 258 10.1016/j.tripleo.2007.01.040 17560140
19. R Diego O D'Orto D Pagani A Agazzi U Marzano G Derada Troletti W Fontanella L Pignataro 2007 Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 e1 e5 10.1016/j.tripleo.2006.09.022 17197204
20. I Dimitrakopoulos C Magopoulos D Karakasis 2006 Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases Int J Oral Maxillofac Surg 35 588 593 10.1016/j.ijom.2006.02.022 1:STN:280: DC%2BD28zms12itQ%3D%3D 16687238 (Pubitemid 43863136)
21. RE Marx 2003 Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 1115 1117 10.1016/S0278-2391(03)00720-1 12966493 (Pubitemid 37064711)
22. RE Marx JE Cillo Jr JJ Ulloa 2007 Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment J Oral Maxillofac Surg 65 2397 2410 10.1016/j.joms.2007.08.003 18022461 (Pubitemid 350100982)
23. SL Ruggiero B Mehrotra TJ Rosenberg SL Engroff 2004 Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases J Oral Maxillofac Surg 62 527 534 10.1016/j.joms.2004.02.004 15122554 (Pubitemid 38542516)
24. F Bertoldo 2008 Bisphosphonates and osteonecrosis of the mandible/maxilla in osteoporosis: no reason to panic Aging Clin Exp Res 20 87 90 18283234
25. VM Cartsos S Zhu AI Zavras 2008 Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714, 217 people J Am Dent Assoc 139 23 30 18167381
26. M Pazianas WA Blumentals PD Miller 2008 Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker Osteoporos Int 19 773 779 10.1007/s00198-007-0502-1 1:CAS:528: DC%2BD1cXltFyjtbo%3D 17999023
27. NH Bell JP Bilezikian HG Bone 3rd A Kaur A Maragoto AC Santora 2002 Alendronate increases bone mass and reduces bone markers in postmenopausal African-American women J Clin Endocrinol Metab 87 2792 2797 10.1210/jc.87.6.2792 1:CAS:528:DC%2BD38XkvFaku7o%3D 12050252 (Pubitemid 34655346)
28. AY Ho AW Kung 2005 Efficacy and tolerability of alendronate once weekly in Asian postmenopausal osteoporotic women Ann Pharmacother 39 1428 1433 10.1345/aph.1E580 1:CAS:528:DC%2BD2MXhtVWjtrvL 16076919 (Pubitemid 41197121)
29. AW Kung SS Yeung LW Chu 2000 The efficacy and tolerability of alendronate in postmenopausal osteoporotic Chinese women: a randomized placebo-controlled study Calcif Tissue Int 67 286 290 10.1007/s002230001142 1:CAS:528: DC%2BD3cXntlOlu78%3D 11000341 (Pubitemid 30736857)
30. JY Leung AY Ho TP Ip G Lee AW Kung 2005 The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study Bone 36 358 364 10.1016/j.bone.2004.10.014 1:CAS:528:DC%2BD2MXhslWksLk%3D 15780963 (Pubitemid 40283594)
31. EG Pasion SK Sivananthan AW Kung SH Chen YJ Chen R Mirasol BK Tay GA Shah MA Khan F Tam BJ Hall D Thiebaud 2007 Comparison of raloxifene and bisphosphonates based on adherence and treatment satisfaction in postmenopausal Asian women J Bone Miner Metab 25 105 113 10.1007/s00774-006-0735-7 1:CAS:528:DC%2BD2sXitVOltb8%3D 17323180 (Pubitemid 46328666)
32. LN Tseng WH Sheu ES Ho HH Lan CC Hu CH Kao 2006 Effects of alendronate combined with hormone replacement therapy on osteoporotic postmenopausal Chinese women Metabolism 55 741 747 10.1016/j.metabol.2006.01.008 1:CAS:528: DC%2BD28Xks1Wqs78%3D 16713432
33. RD Wasnich PD Ross DE Thompson G Cizza AJ Yates 1999 Skeletal benefits of two years of alendronate treatment are similar for early postmenopausal Asian and Caucasian women Osteoporos Int 9 455 460 10.1007/s001980050171 1:STN:280:DC%2BD3c%2FhvFylsA%3D%3D 10550466 (Pubitemid 29231739)
34. MC Farrugia DJ Summerlin E Krowiak T Huntley S Freeman R Borrowdale C Tomich 2006 Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates Laryngoscope 116 115 120 10.1097/01.mlg. 0000187398.51857.3c 16481822 (Pubitemid 44383974)
35. L Levin A Laviv D Schwartz-Arad 2007 Denture-related osteonecrosis of the maxilla associated with oral bisphosphonate treatment J Am Dent Assoc 138 1218 1220 17785387
36. NJ Malden AY Pai 2007 Oral bisphosphonate associated osteonecrosis of the jaws: three case reports Br Dent J 203 93 97 10.1038/bdj.2007.636 1:STN:280:DC%2BD2svktlOjtw%3D%3D 17660780
37. JB Nase JB Suzuki 2006 Osteonecrosis of the jaw and oral bisphosphonate treatment J Am Dent Assoc 137 1115 1119 16873327 quiz 1169-1170
38. N Yarom R Yahalom Y Shoshani W Hamed E Regev S Elad 2007 Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome Osteoporos Int 18 1363 1370 10.1007/s00198-007-0384-2 1:CAS:528:DC%2BD2sXhtVagurrI 17598065 (Pubitemid 47389465)
39. S Khosla D Burr J Cauley DW Dempster PR Ebeling D Felsenberg RF Gagel V Gilsanz T Guise S Koka LK McCauley J McGowan MD McKee S Mohla DG Pendrys LG Raisz SL Ruggiero DM Shafer L Shum SL Silverman CH Van Poznak N Watts SB Woo E Shane 2007 Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research J Bone Miner Res 22 1479 1491 10.1359/jbmr.0707onj 17663640 (Pubitemid 351229318)
40. BT Grant C Amenedo K Freeman RA Kraut 2008 Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases J Oral Maxillofac Surg 66 223 230 10.1016/j.joms.2007.09.019 18201600
41. BM Bell RE Bell 2008 Oral bisphosphonates and dental implants: a retrospective study J Oral Maxillofac Surg 66 1022 1024 10.1016/j.joms.2007.12. 040 18423296
42. HL Wang D Weber LK McCauley 2007 Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report J Periodontol 78 584 594 10.1902/jop.2007.060239 17335384